-
Make the Right Turn at the Next Crossroads
In the latest edition of Drug Topics, senior pharmacist Truman Lastinger describes a scenario for what he describes as Retail Pharmacy in the US. Because US pharmacy is a bit ahead in evolution than Australian pharmacy his comments are very relevant for today’s Australian pharmacy, the practice of which has split into three components- Retail…
-
The Effects of Cannabis On Weight Loss, Exercise Performance and Insulin Resistance
This report is a collection of news items and research reports related to the effects of medical cannabis. Some of this information is anecdotal and has to be validated by formal clinical trials. But if only a fraction of the results claimed by personal users is correct, then we indeed have a very useful substance within…
-
Taking the Initiative with Co-Pay
Chemist Warehouse, as you would have imagined, has taken the initiative to discount the co-pay for PBS prescriptions by $1.00. The impact on a retail pharmacy like the warehouse model is not quite the same as for a community pharmacy, because budgets for retail pharmacies are geared for lower profit percentages combined with higher turnover…
-
Engage with Marijuana Opportunities
With the recent announcement by Minister for Health, Sussan Ley, that Australia will have a single licencing system for the controlled cultivation of cannabis, Australia will now have a streamlined system for medical or scientific cannabis development and production which will avoid some of the problems in other countries where it has not been appropriately…
-
Medical Marijuana Creates Clinical and Financial Opportunity for Pharmacists
The Australian Government intends to amend the Narcotic Drugs Act to allow cannabis to be grown for medicine or science and ensure that Australia is not in breach of international drug treaties. In Australia currently Cannabis is prohibited or otherwise managed through Drug Scheduling: (a) when separately specified in these Schedules; or (b) processed hemp…
-
Clinical Pharmacy – a US Working Model
There is an excellent US publication available online and its title is “Drug Topics”. I probably have some affinity because the range of topics discussed ranges from pharmacy management to clinical pharmacy, somewhat similar to material published in i2P. One recent article caught my eye, and it was titled: The new pharmacy: Revenue streams, Part…
-
3D Drug Printing Becoming Commercialised for Pharmacy Use
The initial burst of enthusiasm that followed a laboratory experiment in the printing of drugs using 3D-technology, was in turn, followed by a hiatus that was due to the problems (needing solutions), of getting the product to market, and registered through the FDA, TGA etc. One of the first companies to emerge with proven functional…
-
Why Large Pharmacies Must Develop
Traditionally, when pharmacists reach a mature point in their business and practice development, they have looked to increase their success by adding a new pharmacy to their collection. And sometimes more than two pharmacies, expanding to the legal limit of five or six (or even more using creative investment practices). While the gross profit capacity…
-
Orthomolecular Treatment for Adverse Effects of Human Papilloma Virus (HPV) Vaccine
Editor’s Note: i2P stands for “Safe Vaccination” and does not support the extreme stances of the “anti-vaxers” or the “pro-vaxers”. For this reason we encourage pharmacists to carefully read the comments contained in the news item below, because they are evidence-based and valid. They highlight the unsafe qualities of one vaccine (HPV) containing aluminium as…
-
New Paradigm Pharmacy Design
Pharmacy Workplaces are fairly sterile places to work in as regards to interaction with co-workers and fulfilment for patients and customers. Design improvement is one of the last items generally considered when setting up a pharmacy because there are many models to view and adapt that are already developed, and can be readily copied. But…